Diagnosis and treatment of calcineurin inhibitor-induced pain syndrome in chronic Kidney disease Stage 5 transplantation

Diagnosis and treatment of calcineurin inhibitor-induced pain syndrome in chronic Kidney disease Stage 5 transplantation

Context: Musculoskeletal pain is a frequent manifestation in postrenal transplant recipients that caused by several diseases. Clinically used calcineurin inhibitors including cyclosporine A and tacrolimus can induce calcineurin inhibitor-induced bone pain syndrome which is characterized by severe pa...

Full description

Bibliographic Details
Main Author:	Fateme Shamekhi Amiri
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Indian Journal of Transplantation
Subjects:	Calcineurin inhibitor-induced pain syndrome cyclosporine A gamma-aminobutyric acid analogs iloprost renal transplant tacrolimus
Online Access:	http://www.ijtonline.in/article.asp?issn=2212-0017;year=2018;volume=12;issue=2;spage=125;epage=135;aulast=Amiri

Similar Items

The Advantages of Polymeric Hydrogels in Calcineurin Inhibitor Delivery
by: Claudia Sandoval-Yañez, et al.
Published: (2020-10-01)

Proteomic Characterization of Urinary Extracellular Vesicles from Kidney-Transplanted Patients Treated with Calcineurin Inhibitors
by: Laura Carreras-Planella, et al.
Published: (2020-10-01)

On the interchangeability of calcineurine inhibitors
by: K. E. Zatolochina, et al.
Published: (2018-02-01)

Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs
by: Catharina Margrethe Lerche, et al.
Published: (2010-09-01)

Tacrolimus for the Treatment of Ulcerative Colitis
by: Katsuyoshi Matsuoka, et al.
Published: (2015-07-01)

A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity
by: Gerold Thölking, et al.
Published: (2019-10-01)

Foremost Concepts in Mechanisms of De Novo Post-Liver Transplantation Malignancy
by: Milena Peruhova, et al.
Published: (2021-06-01)

Approaches to correction of immunosuppressive therapy in chronic nephrotoxicity of calcineurin inhibitors
by: E. S. Stolyarevich, et al.
Published: (2018-08-01)

Variabilité d'origine génétique et épigénétique de la pharmacodynamie des inhibiteurs de la calcineurine en transplantation rénale
by: Pouche, Lucie
Published: (2016)

Active surveillance for adverse events among patients who underwent renal transplantation: A prospective observational study
by: Padmanabhan Guruprasad, et al.
Published: (2017-01-01)

Use of tacrolimus to prevent acute kidney graft rejection in sensitized patients
by: O. N. Rzhevskaya, et al.
Published: (2018-08-01)

Ambulatory monitoring unmasks hypertension among kidney transplant patients: single center experience and review of the literature
by: Eitan Gluskin, et al.
Published: (2019-07-01)

Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
by: Helmschrott M, et al.
Published: (2017-06-01)

The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections
by: Paulina Glowacka, et al.
Published: (2020-07-01)

Early tacrolimus administration induced encephalopathy in a renal transplanted patient; a case report
by: Fatemeh Yaghoubi, et al.
Published: (2017-04-01)

De novo cancer avoidance after renal transplantation: A case–control study on low-dose sirolimus combined with a calcineurin inhibitor
by: Kuo-Hsin Chen, et al.
Published: (2015-06-01)

FIRST EXPERIENCE IN SYSTEMIC ADMINISTRATION OF EVEROLIMUS IN RENAL TRANSPLANTATION FROM EXPANDED CRITERIA DONORS IN RUSSIAN FEDERATION
by: I. V. Uliyankina, et al.
Published: (2017-01-01)

Multiple Adverse Drug Reactions to Calcineurin Inhibitors in a Renal Transplant Patient
by: Raheel Ahmed, et al.
Published: (2021-08-01)

Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
by: Rita Leal, et al.
Published: (2018-03-01)

An Integrated Transcriptomic Approach to Identify Molecular Markers of Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients
by: Erika T. Rhone, et al.
Published: (2021-05-01)

Use of everolimus as an alternative to calcineurin inhibitors in renal allograft recipients: A single South Indian center's experience
by: Manns Manohar John, et al.
Published: (2019-01-01)

Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation
by: Gerhardt T, et al.
Published: (2009-05-01)

Sixteen-Year Cohort of Liver Transplantation in the National Health System in Brazil: Analysis of Immunosuppression Maintenance Therapies
by: Guilherme Fagundes Nascimento, et al.
Published: (2020-10-01)

Molecular Pathways Involved In Calcineurin Inhibitor Nephrotoxicity In Kidney Allograft Transplants
by: Nguyen, Huong
Published: (2011)

Comparison of patient and graft survival in tacrolimus versus cyclosporine-based immunosuppressive regimes in renal transplant recipients – Single-center experience from South India
by: Kiran Chandra Patro, et al.
Published: (2018-01-01)

Tacrolimus‐induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin
by: Brittany D. K. Gratreak, et al.
Published: (2020-01-01)

Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function
by: L.A. Silva, et al.
Published: (2006-01-01)

Inibidores de calcineurina no tratamento das dermatoses alérgicas Calcineurin inhibitors in the treatment of allergic dermatitis
by: Ana Paula Beltran Moschione Castro
Published: (2006-11-01)

Calcineurin inhibitors and arterial hypertension in recipients of solid organs
by: E D Kosmacheva, et al.
Published: (2017-12-01)

Calcineurin inhibitors and arterial hypertension in recipients of solid organs
by: Kosmacheva E.D., et al.
Published: (2017-09-01)

Chemometric modeling of different types of electrochemical data for investigation of the binding and inhibition of calcineurin by cyclosporine
by: Ali R. Jalalvand
Published: (2020-08-01)

Role of Tacrolimus C/D Ratio in the First Year After Pediatric Liver Transplantation
by: Benas Prusinskas, et al.
Published: (2021-06-01)

Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome
by: A Sinha, et al.
Published: (2013-01-01)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
by: Charat Thongprayoon, et al.
Published: (2020-07-01)

The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)
by: Line Aas Mortensen, et al.
Published: (2018-05-01)

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
by: Niklas Bergh, et al.
Published: (2020-04-01)

Tacrolimus-induced pure red cell aplasia in a postrenal transplant patient
by: Prakash Khetan, et al.
Published: (2019-01-01)

Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key
by: Blanca Norero, et al.
Published: (2017-01-01)

Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept
by: Mira Choi, et al.
Published: (2020-08-01)

Impact of calcineurin inhibitors on rat glioma cells viability
by: Jeong Hun Seong, et al.
Published: (2019-05-01)